drugset / Trial / NCT00490399

Trial of Gemcitabine and Cisplatin in Patients With Inoperable Biliary Tract Carcinomas

NCT00490399 ↗

Phase 2 Completed 39 enrolled Eli Lilly and Company
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of gemcitabine and cisplatin in Korean patients with biliary tract (bile tracts of the gallbladder or liver) cancer.

Timeline

Start
2003-03
Primary completion
—
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — —
Subject Gemcitabine Small molecule — —

Indications